American Century Companies Inc. Buys 165,332 Shares of Teladoc Health, Inc. $TDOC

Key Points

• American Century Companies Inc. significantly increased its stake in Teladoc Health by 78.8% during the 1st quarter, now holding 375,050 shares valued at approximately $2.98 million.
• Several institutional investors have also raised their stakes in Teladoc, with National Bank of Canada FI increasing its position by 79.4% in the same quarter.
• Wall Street analysts have mixed ratings on Teladoc, with a consensus target price of $9.80 and most ratings reflecting a "Hold" stance.

American Century Companies Inc. raised its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 78.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 375,050 shares of the health services provider's stock after buying an additional 165,332 shares during the period. American Century Companies Inc. owned 0.21% of Teladoc Health worth $2,985,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the business. Cambridge Investment Research Advisors Inc. boosted its position in Teladoc Health by 60.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after purchasing an additional 15,030 shares during the last quarter. Golden State Wealth Management LLC grew its position in shares of Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after acquiring an additional 1,690 shares during the period. Wedmont Private Capital raised its holdings in shares of Teladoc Health by 20.3% in the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock worth $117,000 after purchasing an additional 2,715 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in Teladoc Health by 22.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock worth $134,000 after acquiring an additional 2,662 shares during the last quarter. Finally, Vontobel Holding Ltd. raised its stake in Teladoc Health by 61.4% in the 1st quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider's stock valued at $171,000 after acquiring an additional 8,152 shares during the period. 76.82% of the stock is owned by institutional investors.

Teladoc Health Trading Down 1.1%

Shares of Teladoc Health stock traded down $0.08 during trading on Tuesday, reaching $7.65. 4,512,235 shares of the stock were exchanged, compared to its average volume of 5,485,458. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The firm has a market cap of $1.35 billion, a price-to-earnings ratio of -6.43 and a beta of 1.84. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The stock's fifty day moving average is $7.80 and its 200 day moving average is $7.94.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The business had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. During the same quarter last year, the firm posted ($0.38) earnings per share. The company's revenue for the quarter was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, equities research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on TDOC shares. Evercore ISI raised their price target on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Mizuho started coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 target price on the stock. Truist Financial decreased their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Tuesday, May 27th. Wells Fargo & Company cut their price target on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Finally, Bank of America decreased their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a report on Wednesday, May 28th. Six analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $9.80.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.